HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David E Tacha Selected Research

Uroplakin II

1/2021Expression of uroplakin II and GATA-3 in bladder cancer mimickers: caveats in the use of a limited panel to determine cell of origin in bladder lesions.
10/2016A combination of p40, GATA-3 and uroplakin II shows utility in the diagnosis and prognosis of muscle-invasive urothelial carcinoma.
7/2014A newly developed uroplakin II antibody with increased sensitivity in urothelial carcinoma of the bladder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David E Tacha Research Topics

Disease

3Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 07/2014
2Carcinoma (Carcinomatosis)
10/2016 - 07/2014
2Neoplasms (Cancer)
07/2014 - 07/2014
1Neoplasm Metastasis (Metastasis)
10/2016
1Lymphatic Metastasis
10/2016
1Triple Negative Breast Neoplasms
07/2014
1Breast Neoplasms (Breast Cancer)
07/2014
1Adenocarcinoma of Lung
12/2013
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2013
1Lung Neoplasms (Lung Cancer)
12/2013
1Prostatic Intraepithelial Neoplasia
03/2004
1Prostatic Neoplasms (Prostate Cancer)
03/2004

Drug/Important Bio-Agent (IBA)

3Uroplakin IIIBA
01/2021 - 07/2014
2Folic Acid (Vitamin M)FDA LinkGeneric
07/2014 - 12/2013
2Biomarkers (Surrogate Marker)IBA
07/2014 - 12/2013
2Proteins (Proteins, Gene)FDA Link
07/2014 - 03/2004
1AntibodiesIBA
10/2016
1Messenger RNA (mRNA)IBA
07/2014
1Uroplakin IIIIBA
07/2014
1Estrogen ReceptorsIBA
07/2014
1Progesterone Receptors (Progesterone Receptor)IBA
07/2014

Therapy/Procedure

1Therapeutics
12/2013